• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤癌治疗策略的综合综述

A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer.

作者信息

Dachani Sudharshan Reddy, Kaleem Mohammed, Mujtaba Md Ali, Mahajan Nilesh, Ali Sayyed A, Almutairy Ali F, Mahmood Danish, Anwer Md Khalid, Ali Mohammad Daud, Kumar Sanjay

机构信息

Department of Pharmacy Practice, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Al-Dawadmi 11961, Saudi Arabia.

Department of Pharmacology, Babasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440037, Maharashtra, India.

出版信息

ACS Omega. 2024 Feb 22;9(9):10030-10048. doi: 10.1021/acsomega.3c09780. eCollection 2024 Mar 5.

DOI:10.1021/acsomega.3c09780
PMID:38463249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10918819/
Abstract

Skin cancer (SC) poses a global threat to the healthcare system and is expected to increase significantly over the next two decades if not diagnosed at an early stage. Early diagnosis is crucial for successful treatment, as the disease becomes more challenging to cure as it progresses. However, identifying new drugs, achieving clinical success, and overcoming drug resistance remain significant challenges. To overcome these obstacles and provide effective treatment, it is crucial to understand the causes of skin cancer, how cells grow and divide, factors that affect cell growth, and how drug resistance occurs. In this review, we have explained various therapeutic approaches for SC treatment via ligands, targeted photosensitizers, natural and synthetic drugs for the treatment of SC, an epigenetic approach for management of melanoma, photodynamic therapy, and targeted therapy for BRAF-mutated melanoma. This article also provides a detailed summary of the various natural drugs that are effective in managing melanoma and reducing the occurrence of skin cancer at early stages and focuses on the current status and future prospects of various therapies available for the management of skin cancer.

摘要

皮肤癌(SC)对医疗保健系统构成全球威胁,如果不及早诊断,预计在未来二十年将显著增加。早期诊断对于成功治疗至关重要,因为随着疾病进展,治愈难度会越来越大。然而,识别新药、取得临床成功以及克服耐药性仍然是重大挑战。为克服这些障碍并提供有效治疗,了解皮肤癌的病因、细胞如何生长和分裂、影响细胞生长的因素以及耐药性如何产生至关重要。在本综述中,我们解释了通过配体、靶向光敏剂、用于治疗皮肤癌的天然和合成药物、用于管理黑色素瘤的表观遗传方法、光动力疗法以及针对BRAF突变黑色素瘤的靶向疗法等各种治疗皮肤癌的方法。本文还详细总结了各种对管理黑色素瘤和降低早期皮肤癌发生率有效的天然药物,并重点介绍了可用于管理皮肤癌的各种疗法的现状和未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/0e9a22943b67/ao3c09780_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/d3785a1a6a62/ao3c09780_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/b4e295cfbb1a/ao3c09780_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/8a1840a8aee0/ao3c09780_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/0e9a22943b67/ao3c09780_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/d3785a1a6a62/ao3c09780_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/b4e295cfbb1a/ao3c09780_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/8a1840a8aee0/ao3c09780_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4058/10918819/0e9a22943b67/ao3c09780_0004.jpg

相似文献

1
A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer.皮肤癌治疗策略的综合综述
ACS Omega. 2024 Feb 22;9(9):10030-10048. doi: 10.1021/acsomega.3c09780. eCollection 2024 Mar 5.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Tuberculosis结核病
4
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.皮肤癌:从传统治疗方法到先进治疗方法的转变之旅。
Mol Cancer. 2023 Oct 6;22(1):168. doi: 10.1186/s12943-023-01854-3.
5
Nanotechnology-empowered strategies in treatment of skin cancer.纳米技术助力皮肤癌治疗策略。
Environ Res. 2023 Oct 15;235:116649. doi: 10.1016/j.envres.2023.116649. Epub 2023 Jul 13.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
8
Melanoma resistance to photodynamic therapy: new insights.黑色素瘤对光动力疗法的耐药性:新见解。
Biol Chem. 2013 Feb;394(2):239-50. doi: 10.1515/hsz-2012-0228.
9
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.《2018年炎症性肠病在加拿大的影响:患有炎症性肠病的儿童和青少年》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.
10
Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance.黑色素瘤治疗的现状与后续步骤:对抗治疗耐药性
Cancers (Basel). 2024 Apr 19;16(8):1571. doi: 10.3390/cancers16081571.

引用本文的文献

1
Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy.变革癌症免疫疗法:新兴的纳米技术驱动药物递送系统以提高治疗效果。
ACS Meas Sci Au. 2024 Nov 15;5(1):31-55. doi: 10.1021/acsmeasuresciau.4c00062. eCollection 2025 Feb 19.
2
Management of triple-negative breast cancer by natural compounds through different mechanistic pathways.天然化合物通过不同作用机制途径对三阴性乳腺癌的管理
Front Genet. 2024 Jul 26;15:1440430. doi: 10.3389/fgene.2024.1440430. eCollection 2024.
3
Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers.

本文引用的文献

1
In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1.体外和体内姜黄素对乳腺癌的预防作用:DNMT1 的作用。
Molecules. 2024 Jan 16;29(2):434. doi: 10.3390/molecules29020434.
2
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.皮肤癌:从传统治疗方法到先进治疗方法的转变之旅。
Mol Cancer. 2023 Oct 6;22(1):168. doi: 10.1186/s12943-023-01854-3.
3
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers.
多中心蛋白质组学全基因组孟德尔随机化研究鉴定黑色素瘤和非黑色素瘤皮肤癌中的因果性血浆蛋白。
Commun Biol. 2024 Jul 13;7(1):857. doi: 10.1038/s42003-024-06538-2.
4
Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities.非黑色素瘤皮肤癌的治疗方法:标准护理和新兴疗法。
Int J Mol Sci. 2024 Jun 27;25(13):7056. doi: 10.3390/ijms25137056.
黑色素瘤中的BRAF突变:生物学特性、治疗意义及循环生物标志物
Cancers (Basel). 2023 Aug 8;15(16):4026. doi: 10.3390/cancers15164026.
4
Effects of saffron and its active constituent crocin on cancer management: A narrative review.藏红花及其活性成分藏花素对癌症治疗的影响:一项叙述性综述。
Longhua Chin Med. 2022;5. doi: 10.21037/lcm-21-72. Epub 2022 Dec 30.
5
Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention.斑蝥素的肝毒性机制:治疗干预的见解与策略
Front Pharmacol. 2023 Jun 13;14:1201404. doi: 10.3389/fphar.2023.1201404. eCollection 2023.
6
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.姜黄和姜黄素在慢性病防治中的作用:来自临床试验的经验教训。
ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14.
7
REV7 in Cancer Biology and Management.癌症生物学与治疗中的REV7
Cancers (Basel). 2023 Mar 11;15(6):1721. doi: 10.3390/cancers15061721.
8
Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation.表没食子儿茶素没食子酸酯(EGCG)是绿茶中的一种活性酚类化合物,通过靶向DNA高甲基化抑制头颈癌细胞的肿瘤生长。
Biomedicines. 2023 Mar 5;11(3):789. doi: 10.3390/biomedicines11030789.
9
An epidemiological study on skin tumors of the elderly in a community in Shanghai, China.中国上海某社区老年人皮肤肿瘤的流行病学研究。
Sci Rep. 2023 Mar 17;13(1):4441. doi: 10.1038/s41598-023-29012-1.
10
Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology.利用纳米技术增强基于5-氨基酮戊酸(ALA)的前药用于光动力疗法的疗效。
Front Pharmacol. 2023 Feb 27;14:1137707. doi: 10.3389/fphar.2023.1137707. eCollection 2023.